Desjardins Global Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $126K | Sell |
1,658
-946
| -36% | -$72.1K | 0.01% | 426 |
|
|
2023
Q3 | $180K | Sell |
2,604
-2,049
| -44% | -$142K | 0.02% | 389 |
|
|
2023
Q2 | $439K | Buy |
4,653
+93
| +2% | +$8.77K | 0.05% | 312 |
|
|
2023
Q1 | $377K | Buy |
4,560
+2,631
| +136% | +$218K | 0.05% | 305 |
|
|
2022
Q4 | $143K | Sell |
1,929
-1,983
| -51% | -$147K | 0.02% | 371 |
|
|
2022
Q3 | $323K | Hold |
3,912
| – | – | 0.04% | 282 |
|
|
2022
Q2 | $371K | Sell |
3,912
-1,569
| -29% | -$149K | 0.05% | 271 |
|
|
2022
Q1 | $644K | Sell |
5,481
-114
| -2% | -$13.4K | 0.06% | 233 |
|
|
2021
Q4 | $725K | Buy |
+5,595
| New | +$725K | 0.06% | 237 |
|